Inventor

GARIBAY PATRICK WILLIAM

DK31 patents

⚠️ This page may combine multiple inventors who share the name “GARIBAY PATRICK WILLIAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GARIBAY PATRICK WILLIAM

NOVO NORDISK AS

Protease stabilized, acylated insulin analogues

Double-acylated GLP-1 compounds

GLP-1 derivatives

Peptides derivatized with A-B-C-D- and their therapeutical use

GLP-1 derivatives and uses thereof

Double-acylated GLP-1 derivatives

Protease stabilized acylated insulin analogues

Double-acylated GLP-1 derivatives

Double-acylated GLP-1 derivatives

EGF(A) analogues with fatty acid substituents

Insulin derivatives

GARIBAY PATRICK WILLIAM

Double-acylated GLP-1 derivatives

Insulin derivative

Insulin derivatives

MADSEN PETER

Protease stabilized, acylated insulin analogues

Insulin analogues with an acyl and alkylene glycol moiety

KODRA JANOS TIBOR

Insulin derivatives

Insulin derivatives

KOFOED JACOB

Double-acylated GLP-1 derivatives with a linker

SPETZLER JANE

Glucagon-Like Peptide-1 derivatives and their pharmaceutical use

KALTHOFF CHRISTOPH

GLP-1 analogues and derivatives

LAU JESPER

GLP-1 derivatives

HUBALEK FRANTISEK

Insulin derivative

MADSEN ALICE RAVN

Double-acylated GLP-1 derivatives

FYNBO CHARLOTTE HARKJAER

Insulin derivatives

JONASSEN IB

Insulin derivative

BEHRENS CARSTEN

Conjugated proteins with prolonged in vivo efficacy

LAU JESPER FAERGEMAN

Semi-recombinant preparation of GLP-1 analogues

NOVO NORDISK HEALTH CARE A G

Pegylated factor VII glycoforms

TAGMOSE TINA MØLLER

FGF21 derivatives with albumin binder A-B-C-D-E- and their use

TAGMOSE TINA MOELLER

N-terminal modified FGF21 compounds